期刊文献+

荷人鼻咽癌裸鼠血内皮抑素的水平变化 被引量:4

Changes of plasma endostatin levels in nude mice bearing human nasopharyngeal carcinoma
下载PDF
导出
摘要 目的 :探讨不同病期荷人鼻咽癌裸鼠血内皮抑素水平的变化 ,及其与肿瘤发展的关系。方法 :采用BALB/C裸小鼠复制荷人鼻咽癌裸鼠模型 ,通过EIA方法测定不同病期荷人鼻咽癌裸鼠血内皮抑素的浓度 ,称取瘤重。结果 :荷瘤鼠血中内皮抑素含量在种瘤 5d组 [(137 6 1± 5 3 4 1) μg/L]或 10d组 [(10 3 0 6± 17 33) μg/L]与正常裸鼠 [(113 5 6± 2 1 74 ) μg/L]比较未见明显差异 (P >0 0 5 ) ,而种瘤 2 0d组、30d组、4 0d组 [(2 12 80± 85 91) μg/L、(2 93 6 3± 6 2 5 3) μg/L、(2 71 5 7± 32 4 5 ) μg/L]显著高于正常裸鼠 (P <0 0 5 )。随着荷瘤时间的延长 ,瘤宿主血内皮抑素含量逐渐升高 ,种瘤 2 0d组明显增高 ,并持续维持在高水平。瘤重与血中内皮抑素含量呈正相关关系 (r=0 6 87)。结论 :提示肿瘤的发展与血内皮抑素含量的变化可能有关。 AIM: To approach the changes of endostatin levels in BALB/c nude mice bearing human nasopharyngeal carcinoma(NPC) in different period (5, 10, 20, 30 and 40 days) and the relationship between endostatin and tumor's development. METHODS: BALB/c nude mice bearing NPC was reproduced by hypodermic implantation of human CNE-2 cells into right-side of axillary fossa. The level of plasma endostation was detected, and the weight of isolated tumors was measured. On the basis of the regulation of these changes, their relationships were explored. RESULTS: At 5 days [(137.61±53.41) μg/L] or 10 days [(103.06±17.33) μg/L] endostatin level had no apparent alternation in comparison with control group [(113.56±21.74) μg/L, P>0.05]. At 20, 30 and 40 days concentration of endostatin[(212.80±85.91) μg/L,(293.63±62.53) μg/L, (271.57±32.45) μg/L, respectively] were higher than that of the control group (P<0.05). Along with the development of the tumors, both the levels of endostatin and tumors weight increased. There was a positive correlation between the level of endostatin and tumor weight (r=0.687, P<0.05). CONCLUSION:These results suggested that endostatin links with the development of NPC.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2002年第10期1238-1240,共3页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金资助项目 (No .990 118)
关键词 鼻咽肿瘤 内皮抑素 小鼠 Nasopharyngeal neoplasms Endostatin Mice, nude
  • 相关文献

参考文献10

  • 1[1]O'Brien TS, Harris AL. Angiogenesis in urological malignancy [J]. Br J Urol,1995,76(6):675-682.
  • 2[2]Saclarides TJ. Angiogenesis in colorectal cancer [J]. Surg Clin N American, 1997,77(1): 253-260.
  • 3[3]Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease [J]. Nat Med, 1995,1(1): 27-31.
  • 4[4]Doehm T, Folkman J, Browder T, et al. Antiangiogenesis therapy of experimental cancer does not induce acquired drug resistance [J]. Nature, 1997, 390(6658): 404-407.
  • 5[5]Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell , 1996, 86(3):353-364.
  • 6[6]O'Reilly MS, Bochm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997,88(2):277-284.
  • 7[7]Feldman AL, Tamarkin L, Paciotti GF, et al. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage Ⅳ clear cell renal cancer [J]. Clin Cancer Res, 2000, 6(12): 4628-4634.
  • 8[8]Dhanabal M, Ramchadran R, Waterman MJF, et al. Endostatin induces endothelial cell apoptosis [J]. J Biol chem, 1999, 274(17): 11721-11726.
  • 9[9]Folkman J. The role of angiogenesis in tumor growth [J] . Semin Cancer Biol, 1992, 3(2): 65-71.
  • 10[10]Ding I, Sun JZ, Fenton B, et al, Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in Mca-4 murine mammary carcinomas [J]. Cancer Res, 2001, 61(2): 526-531 .

同被引文献43

  • 1刘陶文,陈煌基,常捷燕,李西融.鼻咽癌患者血循环Endostatin的水平[J].中国肿瘤生物治疗杂志,2004,11(2):144-145. 被引量:1
  • 2刘陶文,陈煌基,常捷燕,李西融.远处转移鼻咽癌患者血清endostatin的水平及其意义[J].肿瘤,2004,24(5):497-499. 被引量:1
  • 3李晓华,彭英,李湘平,刘雄,李刚.腺相关病毒介导的内皮抑素对鼻咽癌移植瘤生长和转移的抑制作用[J].中华耳鼻咽喉头颈外科杂志,2005,40(12):881-886. 被引量:3
  • 4Folkman J. Anti - angiogenesis: new concept for therapy of solid tumors[J]. Ann Stag, 1972, 175(3): 409- 416.
  • 5O' Belly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell,1997,88(2) : 277 - 285.
  • 6Alberts B. Molecular biology of the cell[M]. 3rd ed. New York and London: Garland Publishing Inc, 1994. 551 - 598.
  • 7Stryer L. Biochemistry[M]. 4 th ed. New York: Freeman and Company, 1995. 911-948.
  • 8Lewin B. Genes VI[M]. New York: Oxford Press and Cell Press Inc, 1997. 1027-1051
  • 9Yoon S, Eto H,Lin CM, et al. Mouse endostatin inhibiting the formation of lung and liver metastases[ J ]. Cancer Res,1999, 59(24) : 6251 - 6256.
  • 10Yamaguchi N, Anand- Apte B, Lee M, et al. Endostatin inhibits VEGF- induced endothelial cell migration and tumor growth independently of zinc binding[J]. EMBO J, 1999, 18(16) : 4414 - 4423.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部